{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:14:07Z","timestamp":1792858447785,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004801","name":"Shota Rustaveli National Science Foundation","doi-asserted-by":"publisher","award":["FR-22-7764"],"award-info":[{"award-number":["FR-22-7764"]}],"id":[{"id":"10.13039\/501100004801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004801","name":"Shota Rustaveli National Science Foundation","doi-asserted-by":"publisher","award":["FR-22-7764"],"award-info":[{"award-number":["FR-22-7764"]}],"id":[{"id":"10.13039\/501100004801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Equity Health"],"DOI":"10.1186\/s12939-025-02535-x","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T17:00:39Z","timestamp":1748883639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Counting the savings: impact of Georgia\u2019s drug policy interventions on households"],"prefix":"10.1186","volume":"24","author":[{"given":"Tsotne","family":"Gorgodze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akaki","family":"Zoidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Gotsadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"2535_CR1","unstructured":"Transforming our World. The 2030 Agenda for Sustainable Development| Department of Economic and Social Affairs. United Nations; 2015 [cited 2024 Dec 26]. Available from: https:\/\/sdgs.un.org\/publications\/transforming-our-world-2030-agenda-sustainable-development-17981"},{"key":"2535_CR2","unstructured":"WHO. Universal Health Coverage Overview. [cited 2024 Dec 26]. Available from: https:\/\/www.who.int\/health-topics\/universal-health-coverage"},{"key":"2535_CR3","unstructured":"Medicines Selection IP, Affordability WHO. 2017 [cited 2024 Dec 26]. Available from: https:\/\/www.who.int\/publications\/m\/item\/access-to-medicines-making-market-forces-serve-the-poor"},{"key":"2535_CR4","unstructured":"Global Health Expenditure Database. Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP). [cited 2025 Apr 7]. Available from: https:\/\/apps.who.int\/nha\/database\/ViewData\/Indicators\/en"},{"key":"2535_CR5","unstructured":"World Health Organization. Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%). [cited 2024 Oct 3]. Available from: https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/out-of-pocket-expenditure-as-percentage-of-current-health-expenditure-(che)-(-)."},{"key":"2535_CR6","unstructured":"Goginashvili K, Nadareishvili M, Habicht T. Can people afford to pay for health care? New evidence on financial protection in Georgia.. Copenhagen: WHO Regional Office for Europe; [cited 2024 Oct 2]. Available from: https:\/\/www.who.int\/europe\/publications\/i\/item\/9789289055802"},{"key":"2535_CR7","doi-asserted-by":"publisher","unstructured":"Gorgodze T, Zoidze A, Catalan JM, Gotsadze G. Breaking the Cycle: Addressing the Drivers of Impoverishing Healthcare Costs in Georgia. medRxiv; 2025 [cited 2025 Feb 7]. p. 2025.01.31.25321173. Available from: https:\/\/www.medrxiv.org\/content\/https:\/\/doi.org\/10.1101\/2025.01.31.25321173v1","DOI":"10.1101\/2025.01.31.25321173v1"},{"key":"2535_CR8","doi-asserted-by":"publisher","unstructured":"Tsuladze A, Zoidze A, Kotrikadze N, Stauke J, Gotsadze G. Breaking Barriers to Universal Health Coverage: Insights from Georgia\u2019s Chronic Disease Medicine Program. medRxiv; 2025 [cited 2025 Apr 2]. p. 2025.02.27.25323038. Available from: https:\/\/www.medrxiv.org\/content\/https:\/\/doi.org\/10.1101\/2025.02.27.25323038v1","DOI":"10.1101\/2025.02.27.25323038v1"},{"issue":"1","key":"2535_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1878-5085-4-8","volume":"4","author":"T Rukhadze","year":"2013","unstructured":"Rukhadze T. An overview of the health care system in Georgia: expert recommendations in the context of predictive, preventive and personalised medicine. EPMA J. 2013;4(1):8.","journal-title":"EPMA J"},{"key":"2535_CR10","unstructured":"Tsikhelashvili, et al. The economic transformation of Georgia in its 20 years of independence. European Initiative\u2013 Liberal Academy Tbilisi; 2013."},{"key":"2535_CR11","unstructured":"World Bank. World Bank Gender Data Portal. [cited 2024 Dec 26]. GDP per capita (current US$). Available from: https:\/\/genderdata.worldbank.org\/en\/indicator\/ny-gdp-pcap-cd"},{"key":"2535_CR12","unstructured":"Circle. Poverty and Gini Coefficients - National Statistics Office of Georgia. [cited 2024 Dec 17]. Available from: https:\/\/www.geostat.ge\/en\/modules\/categories\/192\/living-conditions"},{"key":"2535_CR13","unstructured":"Curatio International Foundation. Barometer Study: Pharmaceutical Sector in Georgia. 2024 [cited 2024 Oct 4]. Available from: https:\/\/curatiofoundation.org\/barometer-study-pharmaceutical-sector-georgia\/"},{"key":"2535_CR14","unstructured":"On the approval of the 2017 state health protection program. Legislative herald of Georgia. 2017. Available from: https:\/\/www.gov.ge\/files\/469_60842_959891_209.pdf"},{"key":"2535_CR15","unstructured":"On introducing changes to the 2017 state health protection programs. 2018. Legislative Herald of Georgia. 2018. Available from: https:\/\/www.gov.ge\/files\/496_67489_413376_430.pdf"},{"key":"2535_CR16","unstructured":"On determination of the list. of state bodies regulating pharmaceutical products of other countries or interstate. Legislateive herald of Georgia; 2022 [cited 2024 Dec 19]. Available from: https:\/\/matsne.gov.ge\/ka\/document\/view\/5355246"},{"key":"2535_CR17","unstructured":"On approval of. methodology, rules and conditions for state regulation of pharmaceutical product price. Legislateive herald of Georgia; 2022 [cited 2024 Dec 19]. Available from: https:\/\/matsne.gov.ge\/en\/document\/view\/5666436"},{"key":"2535_CR18","unstructured":"National Statistics Office of Georgia. Households Incomes and Expenditures. 2024 [cited 2024 Sep 30]. Available from: https:\/\/www.geostat.ge\/media\/63659\/Households-Incomes-and-Expenditures.PDF"},{"key":"2535_CR19","unstructured":"National Statistics Office of Georgia. Households Incomes and Expenditures Survey. [cited 2024 Sep 30]. Available from: https:\/\/www.geostat.ge\/en\/modules\/categories\/128\/databases-of-2009-2016-integrated-household-survey-and-2017-households-income-and-expenditure-survey"},{"issue":"1","key":"2535_CR20","first-page":"348","volume":"46","author":"JL Bernal","year":"2017","unstructured":"Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348\u201355.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"2535_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","volume":"27","author":"AK Wagner","year":"2002","unstructured":"Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299\u2013309.","journal-title":"J Clin Pharm Ther"},{"issue":"6 Suppl","key":"2535_CR22","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.acap.2013.08.002","volume":"13","author":"RB Penfold","year":"2013","unstructured":"Penfold RB, Zhang F. Use of interrupted time series analysis in evaluating health care quality improvements. Acad Pediatr. 2013;13(6 Suppl):S38\u201344.","journal-title":"Acad Pediatr"},{"key":"2535_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/RMHP.S275831","volume":"14","author":"L Li","year":"2021","unstructured":"Li L, Cuerden MS, Liu B, Shariff S, Jain AK, Mazumdar M. Three statistical approaches for assessment of intervention effects: A primer for practitioners. Risk Manag Healthc Policy. 2021;14:757\u201370.","journal-title":"Risk Manag Healthc Policy"},{"issue":"7","key":"2535_CR24","first-page":"1346","volume":"52","author":"A Alkhawaldeh","year":"2023","unstructured":"Alkhawaldeh A, ALBashtawy M, Rayan A, Abdalrahim A, Musa A, Eshah N, et al. Application and use of Andersen\u2019s behavioral model as theoretical framework: A systematic literature review from 2012\u20132021. Iran J Public Health. 2023;52(7):1346\u201354.","journal-title":"Iran J Public Health"},{"key":"2535_CR25","unstructured":"Lumley T, Hoboken R. N.J: Wiley; 2010. 276. (Wiley series in survey methodology)."},{"key":"2535_CR26","unstructured":"Circle. Population and Demography. - National Statistics Office of Georgia. [cited 2024 Dec 12]. Available from: https:\/\/www.geostat.ge\/en\/modules\/categories\/316\/population-and-demography"},{"issue":"3","key":"2535_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2307\/3087468","volume":"33","author":"N Pavenik","year":"2002","unstructured":"Pavenik N. Do pharmaceutical prices respond to potential patient out-of-pocket expenses? Rand J Econ. 2002;33(3):469\u201387.","journal-title":"Rand J Econ"},{"issue":"2","key":"2535_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.euroecorev.2008.03.004","volume":"53","author":"KR Brekke","year":"2009","unstructured":"Brekke KR, Grasdal AL, Holms TH. Regulation and pricing of pharmaceuticals: reference pricing or price cap regulation? Eur Econ Rev. 2009;53(2):170\u201385.","journal-title":"Eur Econ Rev"},{"issue":"12","key":"2535_CR29","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1111\/poms.13246","volume":"29","author":"F Iravani","year":"2020","unstructured":"Iravani F, Mamani H, Nategh E. External reference pricing and parallel imports of pharmaceuticals: A policy comparison. Prod Oper Manage. 2020;29(12):2716\u201335.","journal-title":"Prod Oper Manage"},{"issue":"9","key":"2535_CR30","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.sapharm.2024.06.008","volume":"20","author":"ZUD Babar","year":"2024","unstructured":"Babar ZUD. A conceptual framework to build effective medicine pricing policies for low and middle-income countries (LMICs). Res Social Administrative Pharm. 2024;20(9):934\u20139.","journal-title":"Res Social Administrative Pharm"},{"key":"2535_CR31","unstructured":"Lela Sulaberidze E. al. External reference pricing policy: A possible pharmaceutical price regulation policy in Georgia. Curatio International Foundation; 2022."},{"issue":"2","key":"2535_CR32","first-page":"345","volume":"15","author":"L Maini","year":"2023","unstructured":"Maini L, Pammolli F. Reference pricing as a deterrent to entry: evidence from the European pharmaceutical market. Am Economic Journal: Microeconomics. 2023;15(2):345\u201383.","journal-title":"Am Economic Journal: Microeconomics"},{"key":"2535_CR33","doi-asserted-by":"publisher","first-page":"1034229","DOI":"10.3389\/fphar.2023.1034229","volume":"14","author":"F Babaie","year":"2023","unstructured":"Babaie F, Motevalli MH, Mehralian G, Peiravian F, Yousefi N. How does external reference pricing work in developing countries: evidence from Iran. Front Pharmacol. 2023;14:1034229.","journal-title":"Front Pharmacol"},{"key":"2535_CR34","doi-asserted-by":"publisher","unstructured":"Incze A, Kal\u00f3 Z, Esp\u00edn J, Kiss \u00c9, Kessabi S, Garrison LP. Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications. Front Pharmacol. 2022 Apr 6 [cited 2024 Dec 12];13. Available from: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/https:\/\/doi.org\/10.3389\/fphar.2022.815029\/full","DOI":"10.3389\/fphar.2022.815029\/full"},{"key":"2535_CR35","unstructured":"World Bank. World Bank Open Data. [cited 2025 Apr 3]. GDP per capita (current US$) - Azerbaijan. Available from: https:\/\/data.worldbank.org"},{"key":"2535_CR36","unstructured":"World Bank. World Bank Open Data. [cited 2025 Apr 3]. GDP per capita (current US$) - Ukraine. Available from: https:\/\/data.worldbank.org"},{"key":"2535_CR37","unstructured":"World Bank. World Bank Open Data. [cited 2025 Apr 3]. GDP per capita (current US$) - Moldova. Available from: https:\/\/data.worldbank.org"},{"key":"2535_CR38","unstructured":"Europe WHORO. for. Pharmaceutical pricing and reimbursement systems in eastern Europe and central Asia: report of the Pharmaceutical Pricing and Reimbursement Information network for countries in eastern Europe and central Asia. 2020 [cited 2025 Apr 3]; Available from: https:\/\/iris.who.int\/handle\/10665\/359099"},{"key":"2535_CR39","doi-asserted-by":"crossref","unstructured":"Hsu J, Jowett M, Mills A, Hanson K. What influences the impact of health financing reforms? Using qualitative comparative analysis to identify patterns in health financing systems and their effects on financial protection. SSM - Health Syst. 2025;100055.","DOI":"10.1016\/j.ssmhs.2025.100055"},{"key":"2535_CR40","unstructured":"ERP-evidence-synthesis_20. 01.2022_ENG.pdf. [cited 2024 Dec 12]. Available from: https:\/\/curatiofoundation.org\/wp-content\/uploads\/2022\/01\/ERP-evidence-synthesis_20.01.2022_ENG.pdf"}],"container-title":["International Journal for Equity in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-025-02535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12939-025-02535-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-025-02535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T17:00:46Z","timestamp":1748883646000},"score":1,"resource":{"primary":{"URL":"https:\/\/equityhealthj.biomedcentral.com\/articles\/10.1186\/s12939-025-02535-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2535"],"URL":"https:\/\/doi.org\/10.1186\/s12939-025-02535-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5981851\/v1","asserted-by":"object"}]},"ISSN":["1475-9276"],"issn-type":[{"value":"1475-9276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Although this was secondary analysis of the publicly available anonymized datasets, the research team did obtain the ethical approval from the Health Research Union\u2019s ethical committee (protocol #2024-01, approved 04\/03\/2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}